Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan

Published:2018-09 Issue:9 Volume:24 Page:744-752
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Mikamo Hiroshige^ORCID,Tateda Kazuhiro^ORCID,Yanagihara Katsunori,Kusachi Shinya,Takesue Yoshio,Miki Takashi,Oizumi Yuki,Gamo Kazuaki,Hashimoto Atsuki,Toyoshima Junko,Kato Kenichi

Funder

Sumitomo Dainippon Pharma Co., Ltd

Taisho Toyama Pharmaceutical Co., Ltd

Daiichi Sankyo Co., Ltd

Pfizer Co., Ltd

Astellas, Inc.

MSD K.K.

Toyama Chemical Co., Ltd

MIYARISAN Pharmaceutical Co., Ltd

Shionogi & Co. Ltd.

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference25 articles.

1. Multi-institution case-control and cohort study of risk factors for the development and mortality of Clostridium difficile infections in Japan;Takahashi;BMJ Open,2014

2. Clostridium difficile infection: new developments in epidemiology and pathogenesis;Rupnik;Nat Rev Microbiol,2009

3. Precision microbiome reconstitution restores bile acid-mediated resistance to Clostridium difficile;Buffie;Nature,2015

4. Clostridium difficile associated infection, diarrhea and colitis;Hookman;World J Gastroenterol,2009

5. Incidence and mortality associated with Clostridium difficile infection at a Japanese tertiary care center;Honda;Anaerobe,2014

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Which trial do we need? A sequential multiple assignment randomized trial to determine the optimal Clostridioides difficile treatment sequence;Clinical Microbiology and Infection;2024-02

2. Impact of oral vancomycin treatment duration on rate of Clostridioides difficile recurrence in patients requiring concurrent systemic antibiotics;Infection Control & Hospital Epidemiology;2024-01-30

3. The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes: a systematic review and meta-analysis;Clinical Microbiology and Infection;2024-01

4. Comparative Effectiveness of Fidaxomicin vs Vancomycin in Populations With Immunocompromising Conditions for the Treatment of Clostridioides difficile Infection: A Single-Center Study;Open Forum Infectious Diseases;2023-12-08

5. A Comparison of the Efficacy of Treatment With Fidaxomicin Versus Vancomycin in Clostridioides difficile Infection;Cureus;2023-11-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3